Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$515,962
-$801,270 QoQ
Shares Held
21,427
-54.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,734
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New England Research & Management, Inc. holds $31,997,185 across 8 Drug Manufacturers - General names. PFE ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,527 | $7,498,972 | |
| 2 | ABBV |
AbbVie Inc.
|
24,774 | $6,234,129 | |
| 3 | AMGN |
Amgen Inc
|
11,880 | $4,301,985 | |
| 4 | LLY |
ELI LILLY & Co
|
3,556 | $4,265,173 | |
| 5 | MRK |
Merck & Co., Inc.
|
27,279 | $3,505,351 | |
| 6 | AZN |
Astrazeneca PLC
|
15,893 | $3,013,630 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
21,070 | $2,661,983 | |
| 8 | PFE |
Pfizer Inc
This page
|
21,427 | $515,962 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $515,962 | 21,427 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,317,232 | 46,910 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,388,747 | 55,773 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,177,813 | 46,225 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $1,181,118 | 48,726 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,409,588 | 55,627 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,543,754 | 58,189 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,154,959 | 74,463 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $2,077,570 | 74,252 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $2,227,464 | 80,269 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,100,230 | 72,950 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,615,454 | 78,850 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,958,242 | 80,650 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $3,058,980 | 74,975 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $3,780,384 | 73,778 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $3,243,403 | 74,118 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $3,904,042 | 74,462 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $4,129,744 | 79,771 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $4,504,452 | 76,282 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $3,266,910 | 75,957 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $2,709,167 | 69,182 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $2,612,509 | 72,109 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $2,708,774 | 73,588 | Shares | Sole | 2021-01-07 | |
| 2020-09-30 | $3,037,729 | 82,772 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,717,667 | 83,109 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $2,115,362 | 64,809 | Shares | Sole | 2020-06-15 | |
| No filing history on record for this holder in this stock. | ||||||